Kidney failure: aims for the next 10 years and barriers to success (Q38111133)

29 August 2017

title

Kidney failure: aims for the next 10 years and barriers to success (English)

1 reference

29 August 2017

1 reference

1

1 reference

29 August 2017

Ariela Benigni

2

0 references

Marcello Tonelli

object named as

Marcello Tonelli

15

0 references

Robert William Schrier

14

object named as

Robert W Schrier

1 reference

29 August 2017

13

Arrigo Schieppati

1 reference

29 August 2017

9

Norberto Perico

1 reference

29 August 2017

4

Jean-Pierre Grunfeld

1 reference

29 August 2017

author name string

Fredric O Finkelstein

3

1 reference

29 August 2017

Dominique Joly

5

1 reference

29 August 2017

Ivor Katz

6

1 reference

29 August 2017

Zhi-Hong Liu

7

1 reference

29 August 2017

Toshio Miyata

8

1 reference

29 August 2017

Bernardo Rodriguez-Iturbe

10

1 reference

29 August 2017

Luca Antiga

11

1 reference

29 August 2017

Franz Schaefer

12

1 reference

29 August 2017

language of work or name

English

0 references

publication date

31 May 2013

1 reference

29 August 2017

1 reference

29 August 2017

volume

382

1 reference

29 August 2017

issue

9889

1 reference

29 August 2017

page(s)

353-362

1 reference

Dosing of renal replacement therapy in acute kidney injury

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Epidemiology of acute kidney injury

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Peritoneal dialysis for acute kidney injury in sub-Saharan Africa: challenges faced and lessons learned at Kilimanjaro Christian Medical Centre

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Re-examination of the role of peritoneal dialysis to treat patients with acute kidney injury

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Acute peritoneal dialysis: what is the 'adequate' dose for acute kidney injury?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Comparing continuous venovenous hemodiafiltration and peritoneal dialysis in critically ill patients with acute kidney injury: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Outcome of acute peritoneal dialysis in northern Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

CKD and poverty: a growing global challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Acute kidney injury in late pregnancy in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Effect of fetal and child health on kidney development and long-term risk of hypertension and kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

The clinical importance of nephron mass

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Healthy mothers, healthy children: does maternal demand for antenatal care matter for child health in Nepal?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Globalisation and the prevention and control of non-communicable disease: the neglected chronic diseases of adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Integrated approaches to prevention and control of chronic conditions.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Childhood obesity: the new tobacco

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Chronic kidney disease management--what can we learn from South African and Australian efforts?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Poverty, development, and women: why should we care?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Kidney disease screening program in Japan: history, outcome, and perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Consent for research with biological samples: one-time general consent versus a gift model

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Screening for chronic kidney disease in emerging countries: feasibility and hurdles

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Cost-effectiveness of screening for microalbuminuria among African Americans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Population based screening for chronic kidney disease: cost effectiveness study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Burden of CKD, proteinuria, and cardiovascular risk among Chinese, Mongolian, and Nepalese participants in the International Society of Nephrology screening programs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Screening for proteinuria in US adults: a cost-effectiveness analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Screening, monitoring, and treatment of albuminuria: Public health perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Prevalence of chronic kidney disease in China: a cross-sectional survey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

The future of renoprotection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Quality of care and mortality are worse in chronic kidney disease patients living in remote areas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Has the incidence of end-stage renal disease in the USA and other countries stabilized?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Cardiovascular risk factors and prevention of cardiovascular disease in patients with chronic renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Multidisciplinary team care may slow the rate of decline in renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Predialysis psychoeducational intervention and coping styles influence time to dialysis in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

The impact of population-based identification of chronic kidney disease using estimated glomerular filtration rate (eGFR) reporting.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Effectiveness of a multidisciplinary kidney disease clinic in achieving treatment guideline targets

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Multidisciplinary predialysis education decreases the incidence of dialysis and reduces mortality--a controlled cohort study based on the NKF/DOQI guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Guidelines for the management of chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Predictors of new-onset kidney disease in a community-based population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Lifestyle factors, obesity and the risk of chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

How does proteinuria cause progressive renal damage?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Nonprogressive kidney dysfunction and outcomes in older adults with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Delivery of multifactorial interventions by nurse and dietitian teams in a community setting to prevent diabetic complications: a quality-improvement report

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Chronic kidney disease in the developing world.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

HIV and kidney disease in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Is there an epidemic of HIV Infection in the US ESRD program?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Microalbuminuria in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Preventing renal and cardiovascular risk by renal function assessment: insights from a cross-sectional study in low-income countries and the USA

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Renal epidemiology. The first clinical and epidemiological programme on renal disease in Bolivia: a model for prevention and early diagnosis of renal diseases in the developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

PhRMA survey on the conduct of first-in-human clinical trials under exploratory investigational new drug applications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Ethics at phase 0: clarifying the issues

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Emergence of orphan drugs in the United States: a quantitative assessment of the first 25 years

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Integrative biology of renal disease: toward a holistic understanding of the kidney's function and failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

New era for drug discovery and development in renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

International Rare Disease Research Consortium commits to aggressive goals.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Exome sequencing as a tool for Mendelian disease gene discovery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Simple vertebrate models for chemical genetics and drug discovery screens: lessons from zebrafish and Xenopus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Multiplexed array-based and in-solution genomic enrichment for flexible and cost-effective targeted next-generation sequencing

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

How were new medicines discovered?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Therapeutic potential of complement modulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

The podocyte cytoskeleton--key to a functioning glomerulus in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

A systems view of genetics in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Systems biology of kidney diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Sick-building syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

An update on sick building syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

"Brain drain" of health professionals: from rhetoric to responsible action.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

The Metrics of the Physician Brain Drain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Indian doctors criticise health ministry's plan to curb medical "brain drain".

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Brain drain from developing countries: how can brain drain be converted into wisdom gain?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

South-South entrepreneurial collaboration in health biotech

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Bridging the gaps between research, policy and practice in low- and middle-income countries: a survey of health care providers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Role of remission clinics in the longitudinal treatment of CKD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

CA.R.PE.DI.E.M. (Cardio-Renal Pediatric Dialysis Emergency Machine): evolution of continuous renal replacement therapies in infants. A personal journey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

1 reference

7 January 2021

Isolation of renal progenitor cells from adult human kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Inhibiting angiotensin-converting enzyme promotes renal repair by limiting progenitor cell proliferation and restoring the glomerular architecture

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Urine derived cells are a potential source for urological tissue reconstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Podocyte repopulation contributes to regression of glomerular injury induced by ACE inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Bone marrow contributes to renal parenchymal turnover and regeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

The contribution of bone marrow-derived cells to the development of renal interstitial fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

A novel strategy to enhance mesenchymal stem cell migration capacity and promote tissue repair in an injury specific fashion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Renal fibrosis: novel insights into mechanisms and therapeutic targets.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Embryonic stem cells proliferate and differentiate when seeded into kidney scaffolds.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

Regeneration and experimental orthotopic transplantation of a bioengineered kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

In vivo maturation of functional renal organoids formed from embryonic cell suspensions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960438-9

7 January 2021

10.1016/S0140-6736(13)60438-9

Identifiers

DOI

1 reference

29 August 2017

1 reference